-
-
-
Look Out McDonald's And KFC: Here Comes China's Alan Song
HONG KONG,March 4,2025-- China\'s largest restaurant chains aren\'t as well-known globally as McDonald\'s andKFC. Yet one of the country\'s most successful venture capitalists thinks their internation
Harvest Capital / 03-05
-
-
-
-
Beyond Digital, Resilience Empowers AI-Infused Finance
— Huawei Launches AI-Powered R-A-A-S Framework to Accelerate Financial Institutions\' Comprehensive Digital and Intelligent Transformation in AI Era
HUAWEI / 03-05
-
-
-
-
SK Telecom Signs MoU with Giga Computing and SK Enmove on Liquid Cooling Technology
BARCELONA,Spain,March 5,2025-- SK Telecom (NYSE: SKM) today announced that it has signed a Memorandum of Understanding (MoU) with Giga Computing,a leader in liquid cooling technology,and SK Enmove to
SK Telecom / 03-05
-
-
-
-
XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APAC
- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now,XPOVIO®was successively approved in Thailand,Malaysia and Indonesia,significantly e
Antengene Corporation Limited / 03-05
-
-
-
-
Tech with Heart AI for Good
Data Pulse with AI BEIJING,Feb. 28,2025-- Data is a significant driving force for AI development. How can we fully unleash data\'s potential and make AI utilize it?
-
-
-
-
Foxit Named One of the Best Software Companies on G2's 2025 Best Software Awards
Foxit Also Recognized for Foxit PDF Editor in Best Collaboration & Productivity Products and Foxit eSign in Best Sales Software Products
Foxit / 03-03
-
-
-
-
Ragnarok Landverse Genesis Closed Beta 2 Begins
SINGAPORE,Feb. 28,2025-- Ragnarok Landverse Genesis Closed Beta Test 2 (CBT2) is scheduled to take place from March 17 to 23,2025. This announcement has ignited excitement among Ragnarok Online fans,g
Maxion Pte. Ltd. / 03-03
-
-
-
-
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
HONG KONG,Feb. 27,2025-- Akeso,Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1,a
Akeso, Inc. / 02-28
-
-
-
-
Internet Access: UNESCO and ICANN Join Forces to Improve Linguistic Diversity Online
PARIS and LOS ANGELES,Feb. 27,2025-- UNESCO and the Internet Corporation for Assigned Names and Numbers (ICANN) are announcing a new agreement to enhance linguistic diversity in the digital world. T
ICANN / 02-28
-
-
-
-
Sekisui Specialty Chemicals Achieves ISCC PLUS Certification, Advancing Sustainability in Polymer Production
DALLAS,Feb. 27,2025--Sekisui Specialty Chemicals is proud to announce that it has earned the International Sustainability and Carbon Certification (ISCC PLUS) for a broad suite of its Selvol™ Polyvin
Sekisui Specialty Chemicals / 02-28
-
Technology
Newest
